Back

Practical experience and considerations with aficamten in Europe

30 August 2026 (15:26 - 15:41)
Organised by: Logo
Congress Presentation Part of: Advancements in treatment for oHCM and clinical practice experiences with aficamten Hypertrophic Cardiomyopathy Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Ingo Eitel

University Heart Center, Luebeck (Germany)

3 More presentations in this session

Presentation thumbnail
The evolving landscape of oHCM and aficamten in the clinical setting
Doctor A. Pantazis (London, GB)
Video
Presentation thumbnail
Clinical experience with aficamten from the US
Doctor M. Maron (Burlington, US)
Video
Presentation thumbnail
Advancements in treatment for oHCM and clinical practice experiences with aficamten - Key takeaways and discussion
Video

Access the full session

Session thumbnail
Advancements in treatment for oHCM and clinical practice experiences with aficamten
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 15:26 CET
You may be interested in
thumbnail
Congress Session
Fast forwarding care: advancements in treatment for oHCM and clinical practice advantages with aficamten
10 May 2026
thumbnail
Congress Presentation
Early haemodynamic response but persistent systolic dysfunction after mavacamten interruption in obstructive hypertrophic cardiomyopathy (oHCM): a pharmacist led titration case
28 August 2026
thumbnail
Congress Presentation
Positive cardiac remodeling after cardiac myosin inhibitor therapy
29 August 2026
thumbnail
Congress Presentation
Effect of aficamten on cardiac structure and function in patients with symptomatic nonobstructive hypertrophic cardiomyopathy - Results from the ACACIA-HCM trial
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources